MedPath

Effect of dry needling on spasticity in individuals with chronic stroke

Not Applicable
Completed
Conditions
spasticity, knee and ankle range of motion and function in individuals with chronic stroke.
Spastic hemiplegia
G81.1
Registration Number
IRCT20091130002793N5
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

6 months after a stroke involving cerebral cortical regions
first-ever unilateral stroke
ankle dorsi flexor MMAS spasticity score =2
able to ambulate without supportive device

Exclusion Criteria

recurrent stroke
previous treatment with BTXA in the 6 months preceding the study
progressive or severe neurologic diseases, for example, heart conditions, unstable hypertension, fracture, or implants in the lower extremity
fear to needles
any contraindication for deep dry needling

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spasticity. Timepoint: before intervention, 3 weeks after first session, immediately after last session and 1 week after last session. Method of measurement: Modified Modified Ashworth Scale.
Secondary Outcome Measures
NameTimeMethod
Knee range of motion. Timepoint: before intervention, 3 weeks after first session, immediately after last session and 1 week after last session. Method of measurement: protractor.;Ankle range of motion. Timepoint: before intervention, 3 weeks after first session, immediately after last session and 1 week after last session. Method of measurement: protractor.;Functional activity. Timepoint: before intervention, 3 weeks after first session, immediately after last session and 1 week after last session. Method of measurement: Timed Up and Go test.
© Copyright 2025. All Rights Reserved by MedPath